Work

Post-Marketing Safety of Tazemetostat in Antitumor Therapy: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System

Year: 2025

Type: article

Study design: Observational Study

Source: Cancer Investigation

DOI: 10.1080/07357907.2025.2598038

Authors: Chunyong Xia, Jie Liu, Lanxin Hu, Jun Chen, Lei Zhang

Institutions: Chongqing University, Chongqing Maternal and Child Health Hospital, Children's Hospital of Chongqing Medical University, Chongqing Medical University

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417500467

FWCI:

Cites: 23

Cited by:

Related to: